Characterization of the NOD/scid-[Tg]DR1 mouse expressing HLA-DRB1*01 transgene: a model of SCID-hu mouse for vaccine development

Experimental Hematology

Volumn 35, Issue 8, 2007, Pages 1219-1230

  Camacho, Ramon E ^a,c   Wnek, Richard ^a   Fischer, Paul ^a   Shah, Kashmira ^a   Zaller, Dennis M ^a   Woods, Andrea ^a   La Monica, Nicola ^b   Aurisicchio, Luigi ^b   Fitzgerald Bocarsly, Patricia ^c   Koo, Gloria C ^a,c  

^a MERCK RESEARCH LABORATORIES   (United States)

^b IRBM   (Italy)

^c UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ALPHA2 INTEGRIN; CANCER VACCINE; CARCINOEMBRYONIC ANTIGEN; CD11B ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; ESCHERICHIA COLI ENTEROTOXIN; GAMMA INTERFERON; GLYCOPROTEIN P 15095; HLA DR1 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CELL TRANSPLANTATION; CHIMERA; CHROMOSOME 5; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GRAFT SURVIVAL; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOBIOLOGY; INNATE IMMUNITY; INTERFERON PRODUCTION; LIFESPAN; MACROPHAGE; MALE; MONONUCLEAR CELL; MOUSE; NEWBORN; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; SCID MOUSE; SPLEEN; T LYMPHOCYTE; THYMUS; TRANSGENE; UMBILICAL CORD BLOOD; VACCINE PRODUCTION; XENOTRANSPLANTATION;

ANIMALS; CHROMOSOME MAPPING; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; HLA-DR ANTIGENS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKOCYTES, MONONUCLEAR; MALE; MICE; MICE, INBRED NOD; MICE, SCID; MICE, TRANSGENIC; SPLEEN; T-LYMPHOCYTES;

MUS;

EID: 34447641620     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2007.05.002     Document Type: Article

References (24)

1. Bosma G.C., Custer R.P., and Bosma M.J. A severe combined immunodeficiency mutation in the mouse. Nature 301 (1983) 527-530
2. Kirchgessner C.U., Patil C.K., Evans J.W., et al. DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect. Science 267 (1995) 1178-1183
3. Miller R.D., Hogg J., Ozaki J.H., Gell D., Jackson S.P., and Riblet R. Gene for the catalytic subunit of mouse DNA-dependent protein kinase maps to the scid locus. Proc Natl Acad Sci U S A 92 (1995) 10792-10795
4. Araki R., Fujimori A., Hamatani K., et al. Nonsense mutation at Tyr-4046 in the DNA-dependent protein kinase catalytic subunit of severe combined immune deficiency mice. Proc Natl Acad Sci U S A 94 (1997) 2438-2443
5. McCune J.M., Namikawa R., Kaneshima H., Shultz L.D., Lieberman M., and Weissman I.L. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 241 (1988) 1632-1639
6. Mosier D.E., Gulizia R.J., Baird S.M., and Wilson D.B. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335 (1988) 256-259
7. McCune J.M. Development and applications of the SCID-hu mouse model. Semin Immunol 8 (1996) 187-196
8. Shultz L.D., Ishikawa F., and Greiner D.L. Humanized mice in translational biomedical research. Nat Rev Immunol 7 (2007) 118-130
9. Legrand N., Weijer K., and Spits H. Experimental models to study development and function of the human immune system in vivo. J Immunol 176 (2006) 2053-2058
10. Ishikawa F., Yasukawa M., Lyons B., et al. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice. Blood 106 (2005) 1565-1573
11. Ito M., Hiramatsu H., Kobayashi K., et al. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100 (2002) 3175-3182
12. Shultz L.D., Lyons B.L., Burzenski L.M., et al. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 174 (2005) 6477-6489
13. Yahata T., Ando K., Nakamura Y., et al. Functional human T lymphocyte development from cord blood CD34+ cells in nonobese diabetic/Shi-scid, IL-2 receptor gamma null mice. J Immunol 169 (2002) 204-209
14. Traggiai E., Chicha L., Mazzucchelli L., et al. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 304 (2004) 104-107
15. Camacho R.E., Wnek R., Shah K., et al. Intra-thymic/splenic engraftment of human T cells in HLA-DR1 transgenic NOD/scid mice. Cell Immunol 232 (2004) 86-95
16. Woods A., Chen H.Y., Trumbauer M.E., Sirotina A., Cummings R., and Zaller D.M. Human major histocompatibility complex class II-restricted T cell responses in transgenic mice. J Exp Med 180 (1994) 173-181
17. Rosloniec E.F., Brand D.D., Myers L.K., et al. An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen. J Exp Med 185 (1997) 1113-1122
18. Habu S., Fukui H., Shimamura K., et al. In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice. J Immunol 127 (1981) 34-38
19. Mennuni C., Calvaruso F., Facciabene A., et al. Efficient induction of T-cell responses to carcinoembryonic antigen by a heterologous prime-boost regimen using DNA and adenovirus vectors carrying a codon usage optimized cDNA. Int J Cancer 117 (2005) 444-455
20. Shultz L.D., Schweitzer P.A., Christianson S.W., et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol 154 (1995) 180-191
21. Prochazka M., Gaskins H.R., Shultz L.D., and Leiter E.H. The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency. Proc Natl Acad Sci U S A 89 (1992) 3290-3294
22. Yui M.A., and Rothenberg E.V. Deranged early T cell development in immunodeficient strains of nonobese diabetic mice. J Immunol 173 (2004) 5381-5391
23. Shultz L.D., Lang P.A., Christianson S.W., et al. NOD/LtSz-Rag1null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells. J Immunol 164 (2000) 2496-2507
24. Shultz L.D., Banuelos S., Lyons B., et al. NOD/LtSz-Rag1nullPfpnull mice: a new model system with increased levels of human peripheral leukocyte and hematopoietic stem-cell engraftment. Transplantation 76 (2003) 1036-1042